Association of a rheumatoid arthritis susceptibility variant at the CCL21 locus with premature mortality in inflammatory polyarthritis patients

Documenti analoghi

• Benefit of early treatment in inflammatory polyarthritis patients with anti–cyclic citrullinated peptide antibodies versus those without antibodies
  di: Farragher, Tracey M, et al.
  Pubblicazione: (2010)
• The role of rheumatoid arthritis genetic susceptibility markers in the prediction of erosive disease in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register
  di: Plant, Darren, et al.
  Pubblicazione: (2011)
• Association of the HLA–DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis
  di: Farragher, Tracey M, et al.
  Pubblicazione: (2008)
• Association of Functional Outcome With Both Personal- and Area-Level Socioeconomic Inequalities in Patients With Inflammatory Polyarthritis
  di: Harrison, Mark J, et al.
  Pubblicazione: (2009)
• Reduction of Long-Term Disability in Inflammatory Polyarthritis by Early and Persistent Suppression of Joint Inflammation: Results From the Norfolk Arthritis Register
  di: Scirè, Carlo A, et al.
  Pubblicazione: (2011)